Global Renal Biomarker Market Growth (Status and Outlook) 2025-2031

Global Renal Biomarker Market Growth (Status and Outlook) 2025-2031


The global Renal Biomarker market size is predicted to grow from US$ 1058 million in 2025 to US$ 1351 million in 2031; it is expected to grow at a CAGR of 4.1% from 2025 to 2031.

United States market for Renal Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Renal Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Renal Biomarker is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Renal Biomarker players cover Beckman Coulter (Danaher), Thermo Fisher Scientific, Abbott Laboratories, BioPorto Diagnostics, Astute Medical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Renal Biomarker Industry Forecast” looks at past sales and reviews total world Renal Biomarker sales in 2024, providing a comprehensive analysis by region and market sector of projected Renal Biomarker sales for 2025 through 2031. With Renal Biomarker sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Biomarker industry.

This Insight Report provides a comprehensive analysis of the global Renal Biomarker landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Renal Biomarker portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Biomarker market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Biomarker and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Biomarker.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Biomarker market by product type, application, key players and key regions and countries.

Segmentation by Type:
Functional Biomarker
Up-Regulated Proteins
Others

Segmentation by Application:
Hospitals
Diagnostic Labs
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Beckman Coulter (Danaher)
Thermo Fisher Scientific
Abbott Laboratories
BioPorto Diagnostics
Astute Medical
Randox Laboratories

Please note: The report will take approximately 2 business days to prepare and deliver.


*This is a tentative TOC and the final deliverable is subject to change.*
1 Scope of the Report
2 Executive Summary
3 Renal Biomarker Market Size by Player
4 Renal Biomarker by Region
5 Americas
6 APAC
7 Europe
8 Middle East & Africa
9 Market Drivers, Challenges and Trends
10 Global Renal Biomarker Market Forecast
11 Key Players Analysis
12 Research Findings and Conclusion

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings